Love this caveat in the press release ...
The finger-stick test kit is currently being readied for international sales and an agreement for distribution has been signed for sales to commence in multiple countries including India, Malaysia, Singapore, Nepal, Bangladesh, Sri Lanka, Indonesia, Thailand, Vietnam and Australia. Registration in those countries where such documentation is required is the responsibility of the distributor.
IF sales can "commence" in the countries above, has the distributor already registered the product? If yes, what specific countries?
Remember when DECN touted a distributor who would get Mexican approval?
"In June 2018 the company came to terms with a third international distributor who will sell the company’s products in Mexico, Puerto Rico and in select South American countries. Initially the sales by the distributor will be our GenUltimate! test strips and meters, and our GenSure! test strips and meters. Governmental approval is needed
for these products. This distributor has so far not distinguished themselves."
What about the Bolivian and Spanish connection that went South! ROTF! Interpol and all discussed in the 2016 Annual Report?
The company’s second international agreement is through a South American financier who has businesses in Bolivia and Spain. This group has placed
orders for approximately $17 million in GenUltimate! product, GenUltimate! meters and the company’s new (2017) Firefly! Lancets. Almost 11,000 pieces (units) of GenUltiomate!, 3,000 GenUltimate! meters and cases of lancets have been delivered to Bolivia. In addition, the South America financier has funded the company’s regulatory
applications (through a Spanish pharmaceutical company) with the EU, to gain “CE” marking for its GenUltimate! and GenSure! products in return for the Spanish distribution rights to these two products. And lastly, the South American financier has notified the company that he and those closely associated with him wished to subscribe to a $3.25 million to $5.0 million capital investment in the company. As of this writing the company has not concluded this capital investment but intends to speak to this issue in the upcoming 1Q 2017 Quarterly Report..
Let's not forget about the GenSure! product or Perfect Partner or Paragon Sales or licensing agreements, AND ON AND ON AND ON!
ALL TALK, NO EXECUTION!
GO SEC! GO FDA! GO FBI! GO FTC! GO FINRA! GO INTERPOL!
